Our findings suggest that enhanced GSH biosynthesis and reduced cisplatin-induced oxidative stress are responsible for the eIF2α–ATF4–xCT-mediated chemoresistance in gastric cancer cells. The gene discussed is ATF4; the disease is gastric cancer.